McKesson Launches Oncology Technology and Insights Business

McKesson Corp. has launched  an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer.

Building on McKesson’s experience in community oncology, Ontada combines real-world data and research capabilities with a suite of technologies for oncology clinicians – including the iKnowMed electronic health record system and Clear Value Plus regimen support tool.

McKesson said the benefits that Ontada can offer to providers are further enhanced through its strong relationship with McKesson’s The US Oncology Network, as well as other community oncology practices. “At the US Oncology Network, we collaborate with practices to leverage evidence-driven care to deliver better patient outcomes,” said Michael Seiden, M.D., Ph.D., president of the US Oncology Network, in a statement. “We’re thrilled to have Ontada as a technology partner who shares our vision and will provide us with the tools and insights we need to put patients first.”

One goal is to enable collaboration between life sciences companies and oncology providers. Ontada’s team of data scientists and oncology experts will seek to help life sciences companies leverage evidence-based data and insights to accelerate innovation and improve cancer therapy, while empowering providers to deliver the best care and improved outcomes for patients.

“Ontada reflects McKesson’s continued commitment and investment in the oncology community,” said Brian Tyler, chief executive officer of McKesson, in a press release. “As one of the largest healthcare companies, McKesson is at the center of care delivery, which provides a unique perspective on the complexities of cancer care and the growing needs among providers and life sciences companies. With the launch of Ontada, we can now build upon our differentiated assets in oncology and deliver innovative solutions that help improve patient outcomes.”